`
`Filed: November 7, 2017
`
`
`
`
`
`
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_______________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_______________________
`
`ACTAVIS LLC,
`Petitioner
`v.
`ABRAXIS BIOSCIENCE, LLC,
`Patent Owner
`_______________________
`Case IPR2017-01104
`U.S. Patent No. 8,138,229
`_______________________
`
`
`PATENT OWNER’S RESPONSE TO PETITIONER’S OBJECTIONS TO
`EVIDENCE
`UNDER 37 CFR 42.64(b)(1) and (b)(2)
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.64(b)(1), Petitioner Actavis LLC (“Actavis”)
`
`served objections to evidence submitted by Patent Owner Abraxis Bioscience, LLC
`
`(“Abraxis”) in support of its Patent Owner Preliminary Response to the Petition for
`
`Inter Partes Review of U.S. Patent No. 8,138,229, Case IPR2017-01104. Actavis
`
`raised general objections to Abraxis’s expert declaration and other evidence
`
`without detailing the basis of those objections. Abraxis disagrees with each of
`
`Actavis’s objections and submits supplemental evidence pursuant to 37 C.F.R. §
`
`42.64(b)(2).
`
`If Actavis files a motion to exclude any of the evidence, Abraxis reserves the
`
`right to respond to Actavis’s motion and objections in detail pursuant to 37 C.F.R.
`
`§ 42.23. Abraxis also reserves the right to submit supplemental evidence because
`
`Actavis’s objections are general and vague so as not to provide proper notice as to
`
`the nature of its objections.
`
`
`
`Dated: November 7, 2017
`
`
`
`
`
`/ J. Patrick Elsevier, Ph.D. /
`J. Patrick Elsevier, Ph.D. (Reg. No. 44,668)
`Anthony M. Insogna (Reg. No. 35,203)
`Cary Miller, Ph.D. (Reg. No. 54,708)
`Lisamarie LoGiudice, Ph.D. (Reg. No. 71,047)
`JONES DAY
`4655 Executive Drive, Suite 1500
`San Diego, CA 92121-3134
`Tel: (858) 314-1200
`Fax: (844) 345-3178
`jpelsevier@jonesday.com
`aminsogna@jonesday.com
`
`
`
`-2-
`
`
`
`cmiller@jonesday.com
`llogiudice@jonesday.com
`
`F. Dominic Cerrito (Reg. No. 38,100)
`Andrew S. Chalson (pro hac vice)
`Frank C. Calvosa (Reg. No. 69,064)
`QUINN EMANUEL URQUHART &
`SULLIVAN, LLP
`51 Madison Avenue, 22nd Floor
`New York, NY 10010
`General Tel: (212) 849-7000
`Direct Tel: (212) 849-7450
`Fax: (212) 849-7100
`nickcerrito@quinnemanuel.com
`andrewchalson@quinnemanuel.com
`frankcalvosa@quinnemanuel.com
`
`
`
`
`
`Counsel for Patent Holder
`Abraxis Bioscience, LLC
`
`
`
`-3-
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that on the date indicated below a copy of the
`
`foregoing PATENT OWNER’S RESPONSE TO PETITIONER’S OBJECTIONS
`
`TO EVIDENCE UNDER 37 CFR 42.64(b)(1) and (b)(2) was served electronically
`
`by filing these documents through the PTAB E2E System, as well as by e-mailing
`
`copies to the following counsel of record for Petitioner Actavis LLC:
`
`Lead Counsel
`Samuel S. Park, Reg. No. 59,656
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`AbraxaneIPR@winston.com
`
`
`Dated: November 7, 2017
`
`Backup Counsel
`George C. Lombardi
`Charles B. Klein
`Kevin E. Warner
`Eimeric Reig-Plessis
`
`WINSTON & STRAWN LLP
`35 W. Wacker Drive
`Chicago, IL 60601
`AbraxaneIPR@winston.com
`
`
`
`
`
`/Lisamarie LoGiudice, Ph.D./
`Lisamarie LoGiudice, Ph.D. (Reg. No.
`71,047)
`JONES DAY
`250 Vesey Street
`New York, NY 10281-1047
`Telephone: 212-326-3939
`Facsimile: 212-755-7306
`
`Counsel for Patent Holder
`Abraxis Bioscience, LLC
`
`
`
`
`
`
`